Clinical trials: Healthy Japanese Children Age 2 Years Through 6 Years
Healthy Japanese Children Age 2 Years Through 6 Years
A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years
This open-label, single arm, multicenter study will enroll approximately 100 subjects. The study is designed to gather the safety and tolerability data in Japanese children 2 to 6 years of age that would support approval of…
- Trial name
- NCT02269488
- Testing
- MEDI3250
- Where
- 3 sites in Japan
- Volunteers
- 100 people
- Sponsor
- AstraZeneca